BARBARA ANN KARMANOS CANCER INSTITUTE
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.karmanos.org
Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2013-04-16
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Registration Number
- NCT00268255
Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
- Conditions
- Interventions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2023-03-10
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Target Recruit Count
- 35
- Registration Number
- NCT00258310
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2013-04-29
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Target Recruit Count
- 5
- Registration Number
- NCT00258245
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
- Conditions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2013-04-08
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Registration Number
- NCT00258466
Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2013-04-08
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Registration Number
- NCT00258232
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT00258284
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- First Posted Date
- 2005-11-04
- Last Posted Date
- 2013-04-29
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Target Recruit Count
- 6
- Registration Number
- NCT00248482
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
- First Posted Date
- 2005-11-04
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Target Recruit Count
- 36
- Registration Number
- NCT00248560
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT00244946
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Target Recruit Count
- 19
- Registration Number
- NCT00244933
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States